Skip to main content

Milestone 7.D

Initiate early clinical development for at least 6 existing drugs or drug combinations for the treatment or prevention of AD and AD-related dementias.


Success Criteria

  • Completion of at least 4 phase II trials with repurposed drugs and/or drug combinations. Successful trials will provide conclusive evidence of therapeutic mechanism/target engagement.


Research Implementation Area
Drug Repurposing and Combination Therapy Development
Timeline
2018–2023
Status
In Progress

Implementation Activities

Funding Initiatives

Research Programs and Resources

Research Highlights

Relevant Recommendations